ResMed
NYSE RMD · San Diego, CA
Works in Cardiovascular · Hematology · Immunology · Metabolic & endocrine · Neurology · Oncology · Psychiatry · Respiratory
ResMed is a clinical trial sponsor based in San Diego, CA, listed as NYSE RMD. It has 14 active clinical trials with 2,750 planned participants, across 8 therapeutic areas. Since 2021 it has completed 40 trials and stopped 7 early.
Trial track record · since 2021
Financials · NYSE RMD
Pipeline · 14 active trials
| Stage | Trial | Status |
|---|---|---|
On the market · 0 products
No marketed products under this name.
Questions about ResMed
ResMed is lead sponsor of 14 active clinical trials on ClinicalTrials.gov, with 2,750 planned participants, in Cardiovascular, Hematology, Immunology, Metabolic & endocrine and other areas. Since 2021 it has completed 40 trials and stopped 7 early.
ResMed is based in San Diego, CA and is listed as NYSE RMD. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with ResMed; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-27.
Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-09-25.
Approve Suite is not affiliated with ResMed.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.